Document ID: chunk:federal_register_of_legislation:C2025C00043:clause:3_2941:p2
Version: federal_register_of_legislation:C2025C00043
Segment Type: clause
Provision Reference: sch 3 cl 2941 (pt 2/3)
Character Range: 791048–794019

whether or not absorbable;
 (d) Opacifying preparations for X‑ray examinations and diagnostic reagents designed to be administered to the patient, being unmixed products put up in measured doses or products consisting of two or more ingredients which have been mixed together for such uses;
 (e) Placebos and blinded (or double‑blinded) clinical trial kits for use in recognised clinical trials, put up in measured doses, even if they might contain active medicaments;
 (f) Dental cements and other dental fillings; bone reconstruction cements;
 (g) First‑aid boxes and kits;
 (h) Chemical contraceptive preparations based on hormones, on other products of 2937 or on spermicides;
 (ij) Gel preparations designed to be used in human or veterinary medicine as a lubricant for parts of the body for surgical operations or physical examinations or as a coupling agent between the body and medical instruments;
 (k) Waste pharmaceuticals, that is, pharmaceutical products which are unfit for their original intended purpose due to, for example, expiry of shelf life; and
 (l) Appliances identifiable for ostomy use, that is, colostomy, ileostomy and urostomy pouches cut to shape and their adhesive wafers or faceplates.

Subheading Notes.
 1.‑ For the purposes of 3002.13 and 3002.14, the following are to be treated:
 (a) as unmixed products, pure products, whether or not containing impurities;
 (b) as products which have been mixed:
 (1) the products mentioned in (a) above dissolved in water or in other solvents; and
 (2) the products mentioned in (a) and (b)(1) above with an added stabiliser necessary for their preservation or transport; and
 (3) the products mentioned in paragraph (a) and (b)(1) and (b)(2) above with any other additive.
 2.‑ 3003.60 and 3004.60 cover medicaments containing artemisinin (INN) for oral ingestion combined with other pharmaceutical active ingredients, or containing any of the following active principles, whether or not combined with other pharmaceutical active ingredients: amodiaquine (INN); artelinic acid or its salts; artenimol (INN); artemotil (INN); artemether (INN); artesunate (INN); chloroquine (INN); dihydroartemisinin (INN); lumefantrine (INN); mefloquine (INN); piperaquine (INN); pyrimethamine (INN) or sulfadoxine (INN).

Additional Notes.
 1.‑ 3005 does not cover:
 (a) incontinence pads, whether or not having an adhesive strip (9619); or
 (b) pants or napkins for adults (9619).
 2.‑ Goods that contain vitamins or other products of heading 2936 are excluded from headings 3003 and 3004 unless the goods are goods to which Schedule 2, 3, 4 or 8 to the current Poisons Standard (within the meaning of the Therapeutic Goods Act 1989 and as in force from time to time) applies. Medicaments prepared for intravenous, sub‑cutaneous or intramuscular use are excluded from this Note.
 3.‑ Goods that are dietary or other supplements containing:
 (a) chemicals or compounds of Chapter 28 or 29; or
 (b) plants, or parts